aTyr Pharma
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $190 | $0 | $0 |
Gross Profit | -394 | -21,940 | -387 | -383 |
EBITDA | -14,402 | -25,581 | -19,926 | -15,390 |
EBIT | -14,796 | -25,746 | -20,313 | -15,773 |
Net Income | -13,963 | -25,744 | -19,531 | -14,880 |
Net Change In Cash | 0 | 190 | 0 | 0 |
Free Cash Flow | -12,227 | -20,513 | -13,903 | -15,420 |
Cash | 10,743 | 6,150 | 17,220 | 10,362 |
Basic Shares | 98,010 | 97,153 | 90,120 | 86,485 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $190 | $235 | $353 | $10,386 |
Gross Profit | -1,363 | 235 | 353 | 8,691 |
EBITDA | -76,074 | -66,374 | -52,178 | -44,709 |
EBIT | -77,627 | -67,914 | -54,919 | -46,404 |
Net Income | -74,118 | -64,023 | -50,389 | -45,338 |
Net Change In Cash | 190 | 235 | 353 | 10,386 |
Free Cash Flow | -62,063 | -69,184 | -37,436 | -43,527 |
Cash | 10,743 | 11,055 | 22,544 | 9,981 |
Basic Shares | 92,985 | 74,261 | 53,606 | 28,419 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.14 |
2025-09-30 | -$0.26 |
2025-06-30 | -$0.22 |
